Behavior of some biochemical components of blood of patients with ovarian carcinoma during Ledakrin treatment.
D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D002648:Child; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D009564:Nitracrine / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D011379:Prognosis
D000166:Acridines; D000970:Antineoplastic Agents; D006454:Hemoglobins; D009564:Nitracrine